Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.74 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.74 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.74 |
| ▸ | TP53 | P04637 | 2/20 | 0.74 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.74 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.74 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.74 |
| ▸ | CETP | P11597 | 6/20 | 0.67 |
| ▸ | MEN1 | O00255 | 4/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.67 |
| ▸ | THRB | P10828 | 3/20 | 0.67 |
| ▸ | ASAH1 | Q13510 | 2/20 | 0.65 |
| ▸ | ASAH2 | Q9NR71 | 1/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.58 |
| ▸ | GMNN | O75496 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | GLA | P06280 | 2/20 | 0.52 |
| ▸ | POLB | P06746 | 2/20 | 0.52 |
| ▸ | CXCR5 | P32302 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL315529 | 1.00 | MAPT (0.74) | MAPTCYP2D6MAPK1TP53CYP1A2 | |
| SCHEMBL6419171 | 1.00 | MAPT (0.74) | MAPTCYP2D6MAPK1TP53CYP1A2 | |
| SCHEMBL10025150 | 1.00 | MAPT (0.74) | MAPTCYP2D6MAPK1TP53CYP1A2 | |
| SCHEMBL12451652 | 1.00 | MAPT (0.74) | MAPTCYP2D6MAPK1TP53CYP1A2 | |
| SCHEMBL6410392 | 1.00 | MAPT (0.74) | MAPTCYP2D6MAPK1TP53CYP1A2 | |
| SCHEMBL16216319 | 0.95 | MAPT (0.65) | MAPTCYP2D6MAPK1TP53CYP1A2 | |
| SCHEMBL18069580 | 0.91 | MAPT (0.69) | MAPTCYP2D6MAPK1TP53CYP1A2 | |
| SCHEMBL15385494 | 0.89 | TP53 (0.57) | MAPTCYP2D6MAPK1TP53CYP1A2 | |
| SCHEMBL15385493 | 0.85 | TP53 (0.54) | MAPTCYP2D6MAPK1TP53CYP1A2 | |
| Acetyl Ceramide SCHEMBL58536 | 0.85 | MAPT (1.00) | MAPTCYP2D6MAPK1TP53CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6852892-B2 | Process for the synthesis of sphingosine | GOLDSCHMIDT AG (DE) | 2005-02-08 | — | — | US | disclosed |
| EP-1452520-A1 | A process for the synthesis of sphingosine | Cosmoferm B.V. (NL) | 2004-09-01 | — | — | EP | disclosed |
| US-20030171621-A1 | Process for the synthesis of sphingosine | EVONIK INDUSTRIES AG (DE) | 2003-09-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030171621-A1 | Process for the synthesis of sphingosine | S1PR4, S1PR3, S1PR2 | MAPT 4269/4885CYP2D6 1233/4885MAPK1 1514/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.